Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 209

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Intrapartum Antibiotic Chemoprophylaxis Policies for the Prevention of Group B Streptococcal Disease Worldwide: Systematic Review

Open access
Le Doare, Kirsty, O’Driscoll, Megan, Turner, Kim, Seedat, Farah, Russell, Neal J, Seale, Anna C, Heath, Paul T, Lawn, Joy E, Baker, Carol J, Bartlett, Linda, Cutland, Clare, Gravett, Michael G, Ip, Margaret, Madhi, Shabir A, Rubens, Craig E, Saha, Samir K, Schrag, Stephanie, Sobanjo-ter Meulen, Ajoke, Vekemans, Johan, Kampmann, Beate, for the GBS Intrapartum Antibiotic Investigator Group, Ramoni, Angela, Helmig, Rikke Bek, Makikallio, Kaarin, Asatiani, Tengiz, Fisher, Menachem, Feinstein, Michael, Oz, Yuval, Suzin, Matan Elami, Eisenberg, Vered, Berardi, Alberto, Trehan, Indi, Macad, Georgia Leigh, Lucovnik, Miha, Oluwalana, Claire Nkiruka, Letchworth, Pippa, Jagoutz-Herzlinger, Martin, Muriithi, Francis Githae, Yassen, Kouther Issa, Visser, Gerard, Cooper, Sophie · 2017 · Clinical Infectious Diseases

Abstract

BACKGROUND: Intrapartum antibiotic chemoprophylaxis (IAP) prevents most early-onset group B streptococcal (GBS) disease. However, there is no description of how IAP is used around the world. This article is the sixth in a series estimating the burden of GBS disease. Here we aimed to review GBS screening policies and IAP implementation worldwide. METHODS: We identified data through (1) systematic literature reviews (PubMed/Medline, Embase, Literature in the Health Sciences in Latin America and the Caribbean [LILACS], World Health Organization library database [WHOLIS], and Scopus) and unpublished data from professional societies and (2) an online survey and searches of policies from medical societies and professionals. We included data on whether an IAP policy was in use, and if so whether it was based on microbiological or clinical risk factors and how these were applied, as well as the estimated coverage (percentage of women receiving IAP where indicated). RESULTS: We received policy information from 95 of 195 (49%) countries. Of these, 60 of 95 (63%) had an IAP policy; 35 of 60 (58%) used microbiological screening, 25 of 60 (42%) used clinical risk factors. Two of 15 (13%) low-income, 4 of 16 (25%) lower-middle-income, 14 of 20 (70%) upper-middle-income, and 40 of 44 (91%) high-income countries had any IAP policy. The remaining 35 of 95 (37%) had no national policy (25/33 from low-income and lower-middle-income countries). Coverage varied considerably; for microbiological screening, median coverage was 80% (range, 20%-95%); for clinical risk factor-based screening, coverage was 29% (range, 10%-50%). Although there were differences in the microbiological screening methods employed, the individual clinical risk factors used were similar. CONCLUSIONS: There is considerable heterogeneity in IAP screening policies and coverage worldwide. Alternative global strategies, such as maternal vaccination, are needed to enhance the scope of global prevention of GBS disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cid/cix654

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 209

Metadata

Authors
Le Doare, K., O’Driscoll, M., Turner, K., Seedat, F., Russell, N. J., Seale, A. C., Heath, P. T., Lawn, J. E., Baker, C. J., Bartlett, L., Cutland, C., Gravett, M. G., Ip, M., Madhi, S. A., Rubens, C. E., Saha, S. K., Schrag, S., Sobanjo-ter Meulen, A., Vekemans, J., Kampmann, B., for the GBS Intrapartum Antibiotic Investigator Group, Ramoni, A., Helmig, R. B., Makikallio, K., Asatiani, T., Fisher, M., Feinstein, M., Oz, Y., Suzin, M. E., Eisenberg, V., Berardi, A., Trehan, I., Macad, G. L., Lucovnik, M., Oluwalana, C. N., Letchworth, P., Jagoutz-Herzlinger, M., Muriithi, F. G., Yassen, K. I., Visser, G., & Cooper, S.
Venue
Clinical Infectious Diseases
Published
2017-11-06
Volume
65
Issue
suppl_2
Pages
S143-S151
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2782257589
Cited by
209
References
2
FWCI
3.56
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intrapartum Antibiotic Chemoprophylaxis Policies for the Prevention of Group B Streptococcal Disease Worldwide: Systematic Review. https://app.cochat.ai/papers/10.1093/cid/cix654
The paper
Le Doare, K., O’Driscoll, M., Turner, K., Seedat, F., Russell, N. J., Seale, A. C., Heath, P. T., Lawn, J. E., Baker, C. J., Bartlett, L., Cutland, C., Gravett, M. G., Ip, M., Madhi, S. A., Rubens, C. E., Saha, S. K., Schrag, S., Sobanjo-ter Meulen, A., Vekemans, J., . . . Cooper, S. (2017). Intrapartum Antibiotic Chemoprophylaxis Policies for the Prevention of Group B Streptococcal Disease Worldwide: Systematic Review. Clinical Infectious Diseases. https://doi.org/10.1093/cid/cix654

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.